Lv55
1116 积分 2024-07-19 加入
Direct identification of A-to-I editing sites with nanopore native RNA sequencing
2小时前
待确认
Identification of Bona Fide RNA Editing Sites: History, Challenges, and Opportunities
2小时前
待确认
A circularly permuted CasRx platform for efficient, site-specific RNA editing
2小时前
待确认
High-fidelity AaCas12bMax enables the development of an engineered T cell therapy with enhanced safety and functional fitness
11天前
已完结
CRISPR-engineered T cells in patients with refractory cancer
11天前
已完结
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
11天前
已完结
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
12天前
已完结
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
12天前
已完结
ROS‐mediated PERK‐CHOP pathway plays an important role in cadmium‐induced HepG2 cells apoptosis
12天前
已完结
皖公网安备34019202002308
